Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XRC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,249.95 on August 19, 2025, for the supply of Stelara 90 mg/ml syringes. The delivery order, which carries a firm fixed price and is not subject to any set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and must be completed by September 10, 2025. This award represents a single delivery order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide.
The Defense Logistics Agency's SPE2DB program contract with DMS Pharmaceutical Group establishes the company as a critical supplier within the federal pharmaceutical supply chain, authorizing the distribution of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Stelara, an immunosuppressive biologic medication, represents the type of specialty pharmaceutical product routinely procured through this vehicle to meet the medical supply requirements of military health facilities. DMS Pharmaceutical Group's continued success in securing pharmaceutical delivery orders demonstrates its established capability and reliability as a federal contractor serving defense healthcare procurement needs.
Quick answers
Who was awarded contract SPE2DX25F6XRC?
SPE2DX25F6XRC was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 19, 2025.
How much is contract SPE2DX25F6XRC worth?
The government has obligated $16,250 on SPE2DX25F6XRC.
Is contract SPE2DX25F6XRC an order under another contract?
Yes. SPE2DX25F6XRC is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XRC competed?
The extent of competition for SPE2DX25F6XRC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award